Time To Buy Centene Stock?

1. CNC reported a $0.16 loss per share, missing estimates by $0.39. 2. Stock rose 6% despite a 50% drop year-to-date due to medical cost concerns. 3. Management predicts improved performance in 2026, suggesting potential future growth. 4. CNC's low valuation makes it attractive compared to S&P 500 metrics. 5. Average analyst price target of $44 indicates a potential 55% upside.